Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Nov 14, 2025 · 10-Q · 45 days after period end · 0001493152-25-023399
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$282.73K | -$392.37K | -$1.00M | -$123.64K |
| EPS Diluted | $0.00 | $0.00 | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 14, 2025 · 45 d after period end
